GlassScriptPhysician profile
Dana Klindt
NPI 1982166435
$574.81
in general payments reported to CMS, 2019-2025
12 companies · $227 in 2025
The $227 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $118 · 2024: $229 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $574.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $125.97 | 2024-2025 | Aptima, Sonata Sonography-Guided Transcervical Fibroid Ablation System, Thinprep 2000 Processor |
| Smith+Nephew, INC. | $118.37 | 2023 | Pico 7 |
| Astellas Pharma US INC | $78.53 | 2024 | Veozah |
| Exeltis, USA INC. | $51.21 | 2024-2025 | Slynd |
| Abbvie INC. | $51.20 | 2024-2025 | |
| Mimedx Group, INC. | $28.50 | 2025 | |
| Organon LLC | $25.67 | 2024-2025 | Jada System |
| Shield Therapeutics INC | $23.18 | 2024 | |
| Merck Sharp & Dohme LLC | $21.20 | 2025 | Gardasil 9 |
| Exact Sciences Corporation | $19.95 | 2025 | Cologuard Collection Kit |
| Coopersurgical, INC. | $16.74 | 2025 | Paragard T 380a |
| Sage Therapeutics, LLC | $14.29 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Klindt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.